The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). (Q45891729)

17 December 2017

title

The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). (English)

1 reference

17 December 2017

1 reference

1 reference

Mohit Khera

1

1 reference

17 December 2017

Rajib K Bhattacharya

2

1 reference

17 December 2017

Gary Blick

3

1 reference

17 December 2017

Harvey Kushner

4

1 reference

17 December 2017

Dat Nguyen

5

1 reference

17 December 2017

Martin M Miner

6

1 reference

17 December 2017

publication date

18 November 2011

1 reference

17 December 2017

published in

The Aging Male

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

14-21

1 reference

17 December 2017

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Current guidelines for the diagnosis of testosterone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Testosterone supplementation for depressed men: current research and suggested treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Testosterone and depression: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Responsiveness of the PHQ-9 to Psychopharmacological Depression Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

The accuracy of Patient Health Questionnaire-9 in detecting depression and measuring depression severity in high-risk groups in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Monitoring depression treatment outcomes with the patient health questionnaire-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Testosterone levels and psychological health status in men from a general population: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Low testosterone levels in elderly men with dysthymic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Low free testosterone levels are associated with prevalence and incidence of depressive symptoms in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Increased incidence of diagnosed depressive illness in hypogonadal older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Hypothalamic-pituitary-gonadal axis in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Negative Affect and Plasma Testosterone: A Longitudinal Human Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Plasma and urinary testosterone levels in depressed men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

The relationship between testosterone and sexual function in depressed and healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2011.606513

10.3109/13685538.2011.606513

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017